Tag results:
cardiomyocytes
Endothelial Cell News
CU06-1004 Enhances Vascular Integrity and Improves Cardiac Remodeling by Suppressing Edema and Inflammation in Myocardial Ischemia–Reperfusion Injury
[Experimental and Molecular Medicine] Investigators found that CU06-1004, as a vascular leakage blocker, could improve cardiac function by inhibiting cardiac microvascular endothelial cells' hyperpermeability and subsequently reducing the neutrophil’s plugging and infiltration in infarcted hearts.
ESC & iPSC News
A Versatile and Robust Cell Purification System with an RNA-Only Circuit Composed of microRNA-Responsive ON and OFF Switches
[Science Advances] By designing RNA-only circuits with miRNA-ON and -OFF switch mRNAs that encoded a lethal ribonuclease, Barnase, and its inhibitor, Barstar, the authors efficiently purified specific cell types, including human iPSCs and differentiated cardiomyocytes, without flow cytometry.
Muscle Cell News
Transforming Growth Factor-β in Myocardial Disease
[Nature Review Cardiology] The author summarizes the current evidence on the role of TGFβ signaling in myocardial diseases, focusing on cellular targets and molecular mechanisms, and discussing challenges and opportunities for therapeutic translation.
Muscle Cell News
Aligned Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Improves Contractile Properties through Promoting Unidirectional and Synchronous Cardiomyocyte Contraction
[Biomaterials] Scientists fabricated aligned human cardiac tissue using a micro-processed fibrin gel with inverted V-shaped ridges and elucidated the effect of alignment control on contractile properties.
Extracellular Matrix News
Transforming Growth Factor-β in Myocardial Disease
[Nature Reviews Cardiology] The authors summarize the current evidence on the role of TGFβ signaling in myocardial diseases, focusing on cellular targets and molecular mechanisms, and discuss challenges and opportunities for therapeutic translation.
Immunology of Infectious Disease News
Interaction of SARS-CoV-2 with Cardiomyocytes: Insight into the Underlying Molecular Mechanisms of Cardiac Injury and Pharmacotherapy
[Biomedicine & Pharmacotherapy] The authors provide an overview of the pathways involved with cardiomyocyte in COVID-19 subjects to help promoting pharmacotherapies that can protect against SARS-CoV-2-induced cardiac injuries.